Cannabinoid receptor 2 protects against acute experimental sepsis in mice

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Gui, Huan ^a,b   Sun, Yang ^a   Luo, Zhu Min ^a   Su, Ding Feng ^a   Dai, Sheng Ming ^b   Liu, Xia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DICHLOROBENZOYL) 5 METHOXY 2 METHYL 3 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 2 RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; SYNAPTOTAGMIN I; 1 (2,3 DICHLOROBENZOYL) 5 METHOXY 2 METHYL (2 (MOPHOLIN 4 YL)ETHYL) 1H INDOLE; 1-(2,3-DICHLOROBENZOYL)-5-METHOXY-2-METHYL-(2-(MOPHOLIN-4-YL)ETHYL)-1H-INDOLE; HIGH MOBILITY GROUP B1 PROTEIN; INDOLE DERIVATIVE; INTERLEUKIN 6; MORPHOLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE EXPERIMENTAL SEPSIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EXPERIMENTAL INFECTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEPSIS; SPLEEN CELL; SURVIVAL RATE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; PHOSPHORYLATION; WESTERN BLOTTING; AGONISTS; DRUG EFFECTS;

MUS;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HMGB1 PROTEIN; INDOLES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MORPHOLINES; PHOSPHORYLATION; RECEPTOR, CANNABINOID, CB2; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879299679     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/741303     Document Type: Article

References (50)

1. Annane P. D., Bellissant P. E., Cavaillon J. M., Septic shock. Lancet 2005 365 9453 63 78 2-s2.0-11444249412 10.1016/S0140-6736(04)17667-8
2. Lu Y. C., Yeh W. C., Ohashi P. S., LPS/TLR4 signal transduction pathway. Cytokine 2008 42 2 145 151 2-s2.0-43049179999 10.1016/j.cyto.2008.01.006
3. Puskarich M. A., Emergency management of severe sepsis and septic shock. Current Opinion in Critical Care 2012 18 295 300
4. Xiong Y., Medvedev A. E., Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20. Journal of Leukocyte Biology 2011 90 1141 1148
5. Sachithanandan N., Graham K. L., Galic S., Honeyman J. E., Fynch S. L., Hewitt K. A., Steinberg G. R., Kay T. W., Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes 2011 60 2023 2031
6. Shinohara H., Inoue A., Toyama-Sorimachi N., Nagai Y., Yasuda T., Suzuki H., Horai R., Iwakura Y., Yamamoto T., Karasuyama H., Miyake K., Yamanashi Y., Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. Journal of Experimental Medicine 2005 201 3 333 339 2-s2.0-13644271366 10.1084/jem.20041817
7. Seit-Nebi A., Cheng W., Xu H., Han J., MLK4 has negative effect on TLR4 signaling. Cellular & Molecular Immunology 2012 9 1 27 33
8. Divanovic S., Trompette A., Atabani S. F., Madan R., Golenbock D. T., Visintin A., Finberg R. W., Tarakhovsky A., Vogel S. N., Belkaid Y., Kurt-Jones E. A., Karp C. L., Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. Journal of Endotoxin Research 2005 11 6 363 368 2-s2.0-28444490358 10.1179/096805105X67300
9. Parolaro D., Presence and functional regulation of cannabinoid receptors in immune cells. Life Sciences 1999 65 6-7 637 644 2-s2.0-0033538476 10.1016/S0024-3205(99)00286-6
10. Cabral G. A., Griffin-Thomas L., Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Reviews in Molecular Medicine 2009 11 article e3 2-s2.0-63049105150 10.1017/S1462399409000957
11. McDougall J. J., Yu V., Thomson J., In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints. British Journal of Pharmacology 2008 153 2 358 366 2-s2.0-38349124758 10.1038/sj.bjp.0707565
12. Sanchez Robles E. M., Bagues Arias A., Martin Fontelles M. I., Cannabinoids and muscular pain. Effectiveness of the local administration in rat. European Journal of Pain 2012 16 1116 1127
13. Xu H., Cheng C. L., Chen M., Manivannan A., Cabay L., Pertwee R. G., Coutts A., Forrester J. V., Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. Journal of Leukocyte Biology 2007 82 3 532 541 2-s2.0-34548446421 10.1189/jlb.0307159
14. Tschöp J., Kasten K. R., Nogueiras R., Goetzman H. S., Cave C. M., England L. G., Dattilo J., Lentsch A. B., Tschöp M. H., Caldwell C. C., The cannabinoid receptor 2 is critical for the host response to sepsis. Journal of Immunology 2009 183 1 499 505 2-s2.0-68949083424 10.4049/jimmunol.0900203
15. Csóka B., Németh Z. H., Mukhopadhyay P., Spolarics Z., Rajesh M., Federici S., Deitch E. A., Bátkai S., Pacher P., Haskó G., CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS ONE 2009 4 7 2-s2.0-68149166272 10.1371/journal.pone. 0006409 e6409
16. Kadoi Y., Hinohara H., Kunimoto F., Saito S., Goto F., Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. Critical Care Medicine 2005 33 11 2629 2636 2-s2.0-27944465661 10.1097/01.CCM.0000187010.14426.CC
17. Lehmann C., Kianian M., Zhou J., Kuster I., Kuschnereit R., Whynot S., Hung O., Shukla R., Johnston B., Cerny V., Pavlovic D., Spassov A., Kelly M. E., Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis. Critical Care 2012 16 2, article R47
18. Ye C., Choi J. G., Abraham S., Wu H., Diaz D., Terreros D., Shankar P., Manjunath N., Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proceedings of the National Academy of Sciences of the United States of America 2012 109 21052 21057
19. Hotchkiss R. S., Tinsley K. W., Swanson P. E., Schmieg R. E., Hui J. J., Chang K. C., Osborne D. F., Freeman B. D., Cobb J. P., Buchman T. G., Karl I. E., Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. Journal of Immunology 2001 166 11 6952 6963 2-s2.0-0035338993
20. Kasten K. R., Tschöp J., Goetzman H. S., England L. G., Dattilo J. R., Cave C. M., Seitz A. P., Hildeman D. A., Caldwell C. C., T-cell activation differentially mediates the host response to sepsis. Shock 2010 34 4 377 383 2-s2.0-77957691402 10.1097/SHK.0b013e3181dc0845
21. Valenzano K. J., Tafesse L., Lee G., Harrison J. E., Boulet J. M., Gottshall S. L., Mark L., Pearson M. S., Miller W., Shan S., Rabadi L., Rotshteyn Y., Chaffer S. M., Turchin P. I., Elsemore D. A., Toth M., Koetzner L., Whiteside G. T., Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology 2005 48 5 658 672 2-s2.0-20144388149 10.1016/j.neuropharm.2004.12.008
22. Whiteside G. T., Gottshall S. L., Boulet J. M., Chaffer S. M., Harrison J. E., Pearson M. S., Turchin P. I., Mark L., Garrison A. E., Valenzano K. J., A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833. European Journal of Pharmacology 2005 528 1-3 65 72 2-s2.0-28844447455 10.1016/j.ejphar.2005.10.043
23. Qin Y. H., Dai S. M., Tang G. S., Zhang J., Ren D., Wang Z. W., Shen Q., HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. Journal of Immunology 2009 183 10 6244 6250 2-s2.0-77954176954 10.4049/jimmunol.0900390
24. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K., A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biological and Pharmaceutical Bulletin 1996 19 11 1518 1520 2-s2.0-0029803056
25. Hou S. W., Liu C. Y., Li Y. H., Yu J. Z., Feng L., Liu Y. T., Guo M. F., Xie Y., Meng J., Zhang H. F., Xiao B. G., Ma C. G., Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neuroscience & Therapeutics 2012 18 11 909 917 10.1111/cns.12002
26. Jiang L. Y., Tang S. S., Wang X. Y., Liu L. P., Long Y., Hu M., Liao M. X., Ding Q. L., Hu W., Li J. C., Hong H., PPAR γ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neuroscience & Therapeutics 2012 18 8 659 666 10.1111/j.1755-5949.2012.00341.x
27. Brown M. A., Jones W. K., NF- B action in sepsis: the innate immune system and the heart. Frontiers in Bioscience 2004 9 1201 1217 2-s2.0-2442701946
28. Ding J., Song D., Ye X., Liu S. F., A pivotal role of endothelial-specific NF-kappa;B signaling in the pathogenesis of septic shock and septic vascular dysfunction. Journal of Immunology 2009 183 6 4031 4038 2-s2.0-70349307058 10.4049/jimmunol.0900105
29. Ang S. F., Moochhala S. M., MacAry P. A., Bhatia M., Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-kappaB signaling. PLoS ONE 2011 6 e24535
30. Patial S., Saini Y., Parvataneni S., Appledorn D. M., Dorn G. W., LaPres J. J., Amalfitano A., Senagore P., Parameswaran N., Myeloid-specific GPCR kinase-2 negatively regulates NF- B1p105-ERK pathway and limits endotoxemic shock in mice. Journal of Cellular Physiology 2011 226 3 627 637 2-s2.0-78650656888 10.1002/jcp.22384
31. Zhang H., Moochhala S. M., Bhatia M., Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. Journal of Immunology 2008 181 6 4320 4331 2-s2.0-56149107741
32. Guo W., Liu W., Chen G., Hong S., Qian C., Xie N., Yang X., Sun Y., Xu Q., Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-kappaB pathways. International Immunopharmacology 2012 14 613 619
33. Yu Z., Zhang W., Kone B. C., Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor B. Biochemical Journal 2002 367 1 97 105 2-s2.0-0036797750 10.1042/BJ20020588
34. van der Poll T., Preclinical sepsis models. Surgical Infections 2012 13 287 292
35. Ross R. A., Brockie H. C., Pertwee R. G., Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. European Journal of Pharmacology 2000 401 2 121 130 2-s2.0-0034604755 10.1016/S0014-2999(00)00437-4
36. Romano B., Borrelli F., Fasolino L., The cannabinoid TRPA1 agonist cannaichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. British Journal of Pharmacology 2013 169 213 229
37. Varga K., Wagner J. A., Bridgen D. T., Kunos G., Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB Journal 1998 12 11 1035 1044 2-s2.0-0031823187
38. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajima I., Yamakuchi M., Shimizu H., Matsuo S., Imaizumi H., Maruyama I., Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Analytical Biochemistry 2001 294 1 73 82 2-s2.0-0035399346 10.1006/abio.2001.5015
39. Mukhopadhyay S., Das S., Williams E. A., Moore D., Jones J. D., Zahm D. S., Ndengele M. M., Lechner A. J., Howlett A. C., Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. Journal of Neuroimmunology 2006 181 1-2 82 92 2-s2.0-34347393913 10.1016/j.jneuroim.2006.08.002
40. Gallily R., Breuer A., Mechoulam R., 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor- α production in murine macrophages, and in mice. European Journal of Pharmacology 2000 406 1 R5 R7 2-s2.0-0034613209 10.1016/S0014-2999(00)00653-1
41. Ouyang Y., Hwang S. G., Han S. H., Kaminski N. E., Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Molecular Pharmacology 1998 53 4 676 683 2-s2.0-2642609451
42. Schwarz H., Blanco F. J., Lotz M., Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. Journal of Neuroimmunology 1994 55 1 107 115 2-s2.0-0027999501 10.1016/0165-5728(94)90152-X
43. Oberholzer A., Oberholzer C., Moldawer L. L., Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001 16 2 83 96 2-s2.0-0035434019
44. Aziz M., Jacob A., Yang W. L., Matsuda A., Wang P., Current trends in inflammatory and immunomodulatory mediators in sepsis. Journal of Leukocyte Biology 2013 93 3 329 342 10.1189/jlb.0912437
45. Rittirsch D., Flierl M. A., Ward P. A., Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008 8 10 776 787 2-s2.0-52949118458 10.1038/nri2402
46. Costa B., Giagnoni G., Franke C., Trovato A. E., Colleoni M., Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. British Journal of Pharmacology 2004 143 2 247 250 2-s2.0-4744372178 10.1038/sj.bjp.0705920
47. Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N. O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P. J., The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 2007 152 7 1092 1101 2-s2.0-35649015179 10.1038/sj.bjp.0707460
48. Gasperi V., Dainese E., Oddi S., Sabatucci A., Maccarrone M., GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid- binding receptors. Current Medicinal Chemistry 2013 20 64 78
49. Montaser R., Paul V. J., Luesch H., Marine cyanobacterial Fatty Acid amides acting on cannabinoid receptors. ChemBioChem 2012 13 2676 2681
50. Bouaboula M., Desnoyer N., Carayon P., Combes T., Casellas P., G(i) protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Molecular Pharmacology 1999 55 3 473 480 2-s2.0-0032586885